Lapatinib

Lapatinib

SCHEMBL29351024

CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

EGFRERBB2

The experimentally established mechanism targets of Lapatinib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR known ✓ P00533 17/20 1.00
ERBB2 known ✓ P04626 13/20 1.00
ABCB11 O95342 2/20 1.00
MEN1 O00255 1/20 1.00
PIK3C2B O00750 1/20 1.00
MAP2K7 O14733 1/20 1.00
RIPK2 O43353 1/20 1.00
PIK3C2G O75747 1/20 1.00
STK10 O94804 1/20 1.00
ABL1 P00519 1/20 1.00
INSR P06213 1/20 1.00
RET P07949 1/20 1.00
CYP3A4 P08684 1/20 1.00
PDGFRB P09619 1/20 1.00
SRC P12931 1/20 1.00
CYP3A5 P20815 1/20 1.00
ERBB3 P21860 1/20 1.00
CDK2 P24941 1/20 1.00
KMT2A Q03164 1/20 1.00
KCNH2 Q12809 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lapatinib SCHEMBL8100 1.00 EGFR (1.00) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL16766960 1.00 EGFR (1.00) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL29464189 1.00 EGFR (1.00) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL3232460 0.99 EGFR (0.99) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL3232064 0.99 EGFR (0.99) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL4924110 0.99 EGFR (0.99) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL574229 0.99 EGFR (0.99) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL3637153 0.99 EGFR (0.99) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL18691854 0.99 EGFR (0.97) EGFRERBB2ABCB11MEN1PIK3C2B
Lapatinib SCHEMBL2505835 0.99 EGFR (0.97) EGFRERBB2ABCB11MEN1PIK3C2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 563 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260051533-A1 ANODE SUPPORTED SOLID-STATE ELECTROLYTE SEPARATORS GM GLOBAL TECH OPERATIONS LLC (US) 2026-02-19 US claimed
US-12456755-B2 Electrolyte for lithium secondary battery, and lithium secondary battery comprising same LG ENERGY SOLUTION, LTD. (KR) 2025-10-28 US claimed
EP-4120419-B1 ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG ENERGY SOLUTION LTD (KR) 2025-07-23 EP claimed
WO-2025110454-A1 METHOD FOR RECYCLING WASTE SECONDARY BATTERY ELECTRODE MATERIAL 한국에너지기술연구원 2025-05-30 WO claimed
CN-119315092-A Modified intermediate layer containing sulfonic acid, three-dimensional polymer frame and crosslinked polymer for lithium battery 中国科学院上海硅酸盐研究所 2025-01-14 CN claimed
US-20240413384-A1 Solid-Liquid Composite Electrolyte Including Sulfide-based Solid Electrolyte and High-kosmotropicity Salt-containing Liquid Electrolyte, and Semi-solid-state Rechargeable Batteries UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY (KR) 2024-12-12 US claimed
US-20240413382-A1 Solid-liquid Composite Electrolyte including Sulfide-based Solid Electrolyte and Liquid Electrolyte, and Semi-solid-state Rechargeable Batteries UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY (KR) 2024-12-12 US claimed
US-20240413383-A1 Solid-Liquid Composite Electrolyte Including Sulfide-based Solid Electrolyte and High-concentration Liquid Electrolyte, and Semi-solid-state Rechargeable Batteries UI (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY (KR) 2024-12-12 US claimed
CN-119009132-A High-energy lithium ion battery electrolyte 山东海容电源材料有限公司 2024-11-22 CN claimed
US-20240322244-A1 LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME SILA NANOTECHNOLOGIES, INC. 2024-09-26 US claimed
WO-2023287178-A1 NON-AQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME 주식회사 엘지에너지솔루션 2023-01-19 WO claimed
EP-4120419-A1 ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG Energy Solution, Ltd. (KR) 2023-01-18 EP claimed
CN-115275355-A Mixed ether-based electrolyte for low-temperature lithium battery 中国科学院金属研究所 2022-11-01 CN claimed
CN-114824468-A Multifunctional lithium battery additive containing fluorine and boron substances and application thereof 中国科学院物理研究所 2022-07-29 CN claimed
CN-113140794-B Electrolyte film forming additive and lithium ion battery electrolyte containing same 山东海容电源材料有限公司 2022-07-12 CN claimed
CN-113140793-B High-voltage lithium ion electrolyte and application thereof 山东海容电源材料有限公司 2022-07-12 CN claimed
CN-112271328-B Lithium ion battery electrolyte and lithium ion battery 东莞市创明电池技术有限公司 2022-06-03 CN claimed
WO-2022092831-A1 ELECTROLYTE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME 주식회사 엘지에너지솔루션 2022-05-05 WO claimed
US-20220109146-A1 PERFORMANCE IMPROVEMENTS OF SILICON-DOMINANT ANODE CONTAINING LITHIUM ION BATTERIES THROUGH THE USE OF FLUORINATED ESTER/CARBONATES/AROMATIC COMPOUNDS AND MULTIPLE ADDITIVE COMBINATION CONTAINING ELECTROLYTES ENEVATE CORPORATION 2022-04-07 US claimed
WO-2022072417-A1 PERFORMANCE IMPROVEMENTS OF SILICON-DOMINANT ANODE CONTAINING LITHIUM ION BATTERIES THROUGH THE USE OF FLUORINATED ESTERS/CARBONATES/AROMATIC COMPOUNDS AND MULTIPLE ADDITIVE COMBINATION CONTAINING ELECTROLYTES ENEVATE CORPORATION (US) 2022-04-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260051533-A1 ANODE SUPPORTED SOLID-STATE ELECTROLYTE SEPARATORS XPO4, XPA, CACNA2D4 EGFR 1652/4885ERBB2 1015/4885ABCB11 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.